198 related articles for article (PubMed ID: 35089243)
1. SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report.
Alhalabi M; Eddin KA; Ali F; Abbas A
Medicine (Baltimore); 2022 Jan; 101(4):e28722. PubMed ID: 35089243
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Yamakawa T; Ishigami K; Ohwada S; Kazama T; Hirayama D; Yoshii S; Yamano HO; Nakase H
Clin J Gastroenterol; 2023 Apr; 16(2):187-192. PubMed ID: 36417106
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis: A case report.
Alhalabi M; Eddin KA; Cheha K; Abbas A
Medicine (Baltimore); 2021 Sep; 100(38):e27283. PubMed ID: 34559136
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial.
Kobayashi T; Motoya S; Nakamura S; Yamamoto T; Nagahori M; Tanaka S; Hisamatsu T; Hirai F; Nakase H; Watanabe K; Matsumoto T; Tanaka M; Abe T; Suzuki Y; Watanabe M; Hibi T;
Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):429-437. PubMed ID: 33887262
[TBL] [Abstract][Full Text] [Related]
6. Infliximab rescue therapy in a patient with acute severe ulcerative colitis and coronavirus disease 2019 followed by Escherichia coli 0157:H7 infection: a case report.
Bekić D; Belošić Halle Ž
Croat Med J; 2021 Dec; 62(6):634-637. PubMed ID: 34981697
[TBL] [Abstract][Full Text] [Related]
7. Successful use of infliximab and tacrolimus combination therapy in a patient with ulcerative colitis refractory to infliximab dose intensification plus azathioprine.
Cortes X; Borrás-Blasco J; Fernendez S; Moreno M; Rodríguez J; Molés JR; Casterá E
Int J Clin Pharmacol Ther; 2016 Feb; 54(2):125-8. PubMed ID: 26754306
[TBL] [Abstract][Full Text] [Related]
8. Late-Onset of Acute Severe Ulcerative Colitis: Clinical Case.
Dorofeyev AE; Rassokhina OA; Dorofeyeva AA
Dig Dis; 2017; 35(1-2):45-49. PubMed ID: 28147350
[TBL] [Abstract][Full Text] [Related]
9. Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report.
Rieker L; Hofer J; Petzold G; Ellenrieder V; Amanzada A
BMC Gastroenterol; 2022 Jan; 22(1):22. PubMed ID: 35033015
[TBL] [Abstract][Full Text] [Related]
10. Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel.
Hansen R; Meade S; Beattie RM; Auth MK; Croft N; Davies P; Devadason D; Doherty C; Epstein J; Howarth L; Kiparissi F; Muhammed R; Shivamurthy V; Spray C; Stanton MP; Torrente F; Urs A; Wilson D; Irving PM; Samaan M; Kammermeier J
Gut; 2021 Jun; 70(6):1044-1052. PubMed ID: 32873696
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy.
Türk SM; Öztürk Z; Karataş D; Erkorkmaz Ü; Gönüllü E
Turk J Med Sci; 2022 Apr; 52(2):522-523. PubMed ID: 36161620
[TBL] [Abstract][Full Text] [Related]
12. Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 [PIMS-TS] in a Patient Receiving Infliximab Therapy for Inflammatory Bowel Disease.
Meredith J; Khedim CA; Henderson P; Wilson DC; Russell RK
J Crohns Colitis; 2021 Apr; 15(4):687-691. PubMed ID: 32997749
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.
Alexander JL; Liu Z; Muñoz Sandoval D; Reynolds C; Ibraheim H; Anandabaskaran S; Saifuddin A; Castro Seoane R; Anand N; Nice R; Bewshea C; D'Mello A; Constable L; Jones GR; Balarajah S; Fiorentino F; Sebastian S; Irving PM; Hicks LC; Williams HRT; Kent AJ; Linger R; Parkes M; Kok K; Patel KV; Teare JP; Altmann DM; Goodhand JR; Hart AL; Lees CW; Boyton RJ; Kennedy NA; Ahmad T; Powell N;
Lancet Gastroenterol Hepatol; 2022 Nov; 7(11):1005-1015. PubMed ID: 36088954
[TBL] [Abstract][Full Text] [Related]
14. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.
Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A
World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935
[TBL] [Abstract][Full Text] [Related]
15. [Acute severe ulcerative colitis treated with accelerated infliximab induction. Case report].
Fluxá D; Flores L; Kronberg U; Moreno M; Figueroa C; Ibáñez P; Lubascher J; Simian D; Quera R
Rev Med Chil; 2017 Aug; 145(8):1083-1088. PubMed ID: 29189869
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis.
Singh S; Murad MH; Fumery M; Sedano R; Jairath V; Panaccione R; Sandborn WJ; Ma C
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1002-1014. PubMed ID: 34688373
[TBL] [Abstract][Full Text] [Related]
17. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis.
Mazza S; Sorce A; Peyvandi F; Vecchi M; Caprioli F
Gut; 2020 Jun; 69(6):1148-1149. PubMed ID: 32245909
[No Abstract] [Full Text] [Related]
18. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Liu Z; Le K; Zhou X; Alexander JL; Lin S; Bewshea C; Chanchlani N; Nice R; McDonald TJ; Lamb CA; Sebastian S; Kok K; Lees CW; Hart AL; Pollok RC; Boyton RJ; Altmann DM; Pollock KM; Goodhand JR; Kennedy NA; Ahmad T; Powell N;
Lancet Gastroenterol Hepatol; 2023 Feb; 8(2):145-156. PubMed ID: 36481043
[TBL] [Abstract][Full Text] [Related]
19. Treatment of ulcerative colitis.
Blonski W; Buchner AM; Lichtenstein GR
Curr Opin Gastroenterol; 2014 Jan; 30(1):84-96. PubMed ID: 24285003
[TBL] [Abstract][Full Text] [Related]
20. Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial.
Balram B; Joshi H; Wong K; Kroeker KI; Dieleman LA; Halloran BP; Baumgart DC; Peerani F
Dig Dis Sci; 2021 Nov; 66(11):3985-3992. PubMed ID: 33184796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
